Prospects for New Hormonal Male Contraceptives

Akhtar, 1983, Testosterone supplementation attenuates the antifertility effects of an LHRH agonist in male rhesus monkeys, Int J Androl, 6, 461, 10.1111/j.1365-2605.1983.tb00560.x Akhtar, 1983, Reversible induction of azoospermia in rhesus monkeys by constant infusion of a gonadotropin-releasing hormone agonist using osmotic minipumps, J Clin Endocrinol Metab, 56, 534, 10.1210/jcem-56-3-534 Alen, 1985, Serum lipids in power athletes self-administering testosterone and anabolic steroids, Int J Sports Med, 6, 139, 10.1055/s-2008-1025827 Allensbach Umfragen No. 1020 (1958) and No. 5053 (1989) Alvarez-Sanchez, 1977, Attainment and maintenance of azoospermia with combined monthly injections of depot medroxyprogesterone acetate and testosterone enanthate, Contraception, 15, 635, 10.1016/S0010-7824(77)80002-4 Arimura, 1979, Reduction of testicular luteinizing hormone/human chorionic gonadotropin receptors by (D-Trp6)-luteinizing hormone releasing hormone in hypophsectomized rats, Biochem Biophys Res Commun, 90, 687, 10.1016/0006-291X(79)91882-5 Arsyad, 1993, Sperm function in Indonesian men treated with testosterone enanthate, Int J Androl, 16, 355, 10.1111/j.1365-2605.1993.tb01362.x Auclair, 1977, Potent inhibitory activity of (D-Leu)6, Des-Gly-NH210) LHRH ethylamide on LH/hCG and PRL testicular receptor levels in the rat, Endocrinology, 101, 1890, 10.1210/endo-101-6-1890 Bagatell, 1994, Physiological levels of estradiol stimulate plasma high density lipoprotein2 cholesterol levels in normal men, J Clin Endocrinol Metab, 78, 855 Bagatell, 1992, Physiologic testosterone levels in normal men suppress high-density lipoprotein cholesterol levels, Ann Intern Med, 116, 967, 10.7326/0003-4819-116-12-967 Bagatell, 1993, Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens, J Clin Endocrinol Metab, 77, 427 Bagatell, 1989, A comparison of the suppressive effects of testosterone and a potent new GnRH antagonist on gonadotropin and inhibin levels in normal men, J Clin Endocrinol Metab, 69, 43, 10.1210/jcem-69-1-43 Bals-Pratsch, 1986, Transdermal testosterone substitution therapy for male hypogonadism, Lancet, 2, 943, 10.1016/S0140-6736(86)90600-8 Bambino, 1980, Gonadotropin-releasing hormone and its agonist inhibit testicular luteinizing hormone receptor and steroidogenesis in immu-ture and adult hypophysectomized rats, Endocrinology, 107, 908, 10.1210/endo-107-4-908 Barfield, 1979, Pregnancies associated with sperm concentrations below 10 million/ml in clinical studies of a potential male contraceptive method, monthly depot medroxyprogesterone acetate and testosterone esters, Contraception, 20, 121, 10.1016/0010-7824(79)90084-2 Bartlett, 1989, Differential effects of FSH and testosterone on the maintenance of spermatogenesis in the adult hypophysectomized rat, J Endocrinol, 121, 49, 10.1677/joe.0.1210049 Bastias, 1993, Sperm motion parameters after suppression of spermatogenesis with a gonadotropin-releasing hormone antagonist plus testosterone supplementation, Fertil Steril, 59, 1261, 10.1016/S0015-0282(16)55987-1 Behre, 1994, Sustained suppression of serum LH, FSH, and testosterone and increase of high-density lipoprotein cholesterol by daily injections of the GnRH antagonist cetrorelix over 8 days in normal men, J Clin Endocrinol Metab, 40, 241 Behre, 1992, Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception, J Clin Endocrinol Metab, 74, 84 Behre, 1992, Testosterone buciclate (20 Aet-1) in hypogonadal men: Pharmacokinetics and pharmacodynamics of the new long-acting androgen ester, J Clin Endocrinol Metab, 75, 1204 Behre, 1992, Parmacokinetics of the gonadotropin-releasing hormone agonist buserelin after injection of a slow-release preparation in normal men, Arzneim-Forsch, 42, 80 Berent, 1982, 33 Bergquist, 1979, Inhibitory effects on gonadotrophin secretion and gonadal function in men during chronic treatment with a potent stimulatory luteinizing hormone-releasing hormone analogue, Acta Endocrinol, 91, 601, 10.1530/acta.0.0910601 Bhasin, 1988, Dissociating antifertility effects of GnRH-antagonist from its adverse effects on mating behavior in male rats, Am J Physiol, 17, E84 Bhasin, 1987, Testosterone selectivity increases serum follicle-stimulating hormonal (FSH) but not luteinizing hormone (LH) in gonadotropin-releasing hormone antagonist-treated male rats: Evidence for differential regulation of LH and FSH secretion, Biol Reprod, 37, 55, 10.1095/biolreprod37.1.55 Bhasin, 1984, Hormonal effects of GnRH agonist in the human male: II. Testosterone enhances gonadotrophin suppression induced by GnRH agonist, Clin Endocrinol, 20, 119, 10.1111/j.1365-2265.1984.tb00066.x Bhasin, 1985, Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male: III. Effects of long term combined treatment with GnRH agonist and androgen, J Clin Endocrinol Metab, 60, 998, 10.1210/jcem-60-5-998 Bhasin, 1985, Does constant infusion of gonadotropin-releasing hormone agonist lead to greater suppression of gonadal function in man than its intermittent administration?, Fertil Steril, 44, 96, 10.1016/S0015-0282(16)48684-X Bhasin, 1994, Testosterone increases lean body mass, muscle size and strength in hypogonadal men, Clin Res, 42, 74 Bhasin, 1986, Mechanisms of gonadotropin-releasing hormone agonist action in the human male, Endocrinol Rev, 7, 106, 10.1210/edrv-7-1-106 Bhasin, 1992, A biodegradable testosterone microcapsule formulation provides uniform eugonadal levels of testosterone for 10-11 weeks in hypogonadal men, J Clin Endocrinol Metab, 74, 75 Bhasin, 1987, Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in men: Effects of long term treatment with GnRH agonist infusion and androgen, J Clin Endocrinol Metab, 65, 568, 10.1210/jcem-65-3-568 Bianchi, 1989, Treatment of complicated benign prostatic hyperplasia with LHRH-analogues in aged patients, Int J Androl, 12, 104, 10.1111/j.1365-2605.1989.tb01292.x Bienstock, 1993, Conformational analysis of a highly potent dicyclic gonadotropin-releasing hormone antagonist by nuclear magnetic resonance and molecular dynamics, J Med Chem, 36, 3265, 10.1021/jm00074a006 Bongaarts, 1984, Implications of future fertility trends for contraceptive practice, Popul Dev Rev, 10, 341, 10.2307/1973086 Bouchard, 1987, Influence of testosterone substitution on sperm suppression by LHRH agonists, Horm Res, 28, 175, 10.1159/000180942 Bourne, 1980, Testicular GnRH receptors: Characterization and localization on interstitial tissue, J Clin Endocrinol Metab, 51, 407, 10.1210/jcem-51-2-407 Bremner, 1991, Gonadotropin-releasing hormone antagonist plus testosterone: A potential male contraceptive, J Clin Endocrinol Metab, 73, 465, 10.1210/jcem-73-3-465 Brenner, 1977, Study of medroxyprogesterone acetate and testosterone enanthate as a male contraceptive, Contraception, 15, 679, 10.1016/S0010-7824(77)80005-X Burger, 1984, Therapeutic considerations and results of gonadotropin treatment in male hypogonadotropic hypogonadism, Ann NY Acad Sci, 438, 447, 10.1111/j.1749-6632.1984.tb38305.x Burgos-Briceno, 1984, Inhibition of serum luteinizing hormone and testosterone with an inhibitory analog of LHRH in adult male rhesus monkeys, J Clin Endocrinol Metab, 59, 601, 10.1210/jcem-59-4-601 1986, Direction de la Sante de la Mere et de l’Enfant and Columbia University Center for Population and Family Health, 96 Cantrill, 1984, Which testosterone replacement therapy?, Clin Endocrinol, 21, 97, 10.1111/j.1365-2265.1984.tb03448.x Christensen, 1994, Levonorgestrel plus testosterone as a potential male contraceptive, Clin Res, 42, 73 Clayton, 1982, Absence of gonadotropin-releasing hormone receptors in human gonadal tissue, Nature, 299, 56, 10.1038/299056a0 Clayton, 1980, Direct inhibition of testicular function by gonadotropin releasing hormone: Mediation by specific gonadotropin-releasing hormone receptors in interstitial cells, Proc Natl Acad Sci USA, 77, 4459, 10.1073/pnas.77.8.4459 Coleman, 1983 Conway, 1988, Randomized clinical trial of testoterone replacement therapy in hypogonadal men, Int J Androl, 11, 247, 10.1111/j.1365-2605.1988.tb00999.x Crist, 1985, Alphalipoproteinemic effects of androgenic-anabolic steroids in athletes, Ann Sports Med, 2, 125 Cunningham, 1979, Persistence of complete spermatogenesis in the presence of low intratesticular concentrations of testosterone, Endocrinology, 105, 177, 10.1210/endo-105-1-177 Cunningham, 1977, Clinical evaluation of testosterone enanthate for induction and maintenance of reversible azoospermia in man, 71 Dahl, 1986, The changing ratio of serum bioactive to immunoreactive follicle-stimulating hormone in normal men following treatment with a potent gonadotropin releasing hormone antagonist, J Clin Endocrinol Metab, 63, 792, 10.1210/jcem-63-3-792 Davidson AR, Ahn K.C, Chandra S, et al: The acceptability of new contraceptive methods for men. In 113th Annual Meeting of the American Public Health Association, Washington, DC, 1985, p 34 Delanoe, 1984, Androgenisation of female partners of men on medroxyprogesterone acetate/percutaneous testosterone contraception, Lancet, 1, 276, 10.1016/S0140-6736(84)90144-2 Deys, 1973, Condoms and things, Adv Biosci, 10, 286 Deys, 1975, Factors affecting patient motivation, 210 Doelle, 1983, Combined treatment with an LHRH agonist and testosterone in man, J Androl, 4, 298, 10.1002/j.1939-4640.1983.tb02373.x Eri, 1993, A prospective, placebo-controlled study of the luteinizing hormone-releasing hormone agonist leuprolide as treatment for patients with benign prostatic hypertrophy, J Urol, 150, 359, 10.1016/S0022-5347(17)35483-6 Evans, 1984, Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men, J Clin Endocrinol Metab, 58, 862, 10.1210/jcem-58-5-862 Evans, 1984, A luteinizing hormone-releasing hormone agonist decreases biological activity and modifies chromatographic behavior of luteinizing hormone in man, J Clin Invest, 73, 262, 10.1172/JCI111200 1985 Faundes, 1981, Sperm suppression with monthly injections of medroxyprogesterone acetate combined with testosterone enanthate at a high dose (500 mg), Int J Androl, 4, 235, 10.1111/j.1365-2605.1981.tb00707.x Fincham, 1990, Epidemiology of prostate cancer: A case control study, Prostate, 17, 189, 10.1002/pros.2990170303 Foegh, 1980, Clinical evaluation of long-term treatment with levo-norgestrel and testosterone enanthate in normal men, Contraception, 21, 631, 10.1016/0010-7824(80)90035-9 Fogh, 1979, The effects of low doses of cyproterone acetate on some functions of the reproductive system in normal men, Acta Endocrinol, 91, 545, 10.1530/acta.0.0910545 Fogh, 1980, Clinical trial with levo-norgestrel and testosterone oenanthate for male fertility control, Acta Endocrinol, 95, 251, 10.1530/acta.0.0950251 Frick, 1986, Effects of a potent LHRH-agonist on the pituitary gonadal axis with and without testosterone substitution, Urol Res, 14, 261, 10.1007/BF00256570 Frick, 1977, The effects of monthly depot medroxyprogesterone acetate and testosterone on human spermatogenesis. I. Uniform dosage levels, Contraception, 15, 649, 10.1016/S0010-7824(77)80003-6 Frick, 1977, The effects of monthly depot medroxyprogesterone acetate and testosterone on human spermatogenesis. II. High initial dose, Contraception, 15, 669, 10.1016/S0010-7824(77)80004-8 Friedl, 1990, High-density lipoprotein cholesterol is not decreased if an aromatizable androgen is administered, Metabolism, 39, 69, 10.1016/0026-0495(90)90150-B Friedl, 1985, Transient reduction in serum HDL-cholesterol following medroxyprogesterone acetate and testosterone cypionate administration to healthy men, Contraception, 31, 409, 10.1016/0010-7824(85)90007-1 Furman, 1958, The influence of androgens, estrogens and related steroids on serum lipids and lipoproteins, Am J Med, 24, 80, 10.1016/0002-9343(58)90364-4 Gabrilove, 1987, Effect of a GnRH analogue (leuprolide) on benign prostatic hypertrophy, J Clin Endocrinol Metab, 64, 1331, 10.1210/jcem-64-6-1331 Giwercman, 1986, The effect of salicylazosulphapyridine (sulphasalazine) on male fertility. A review, Int J Androl, 9, 38, 10.1111/j.1365-2605.1986.tb00866.x Glass, 1974, Use-effectiveness of the condom in a selected family planning clinic population in the United Kingdom, Contraception, 10, 591, 10.1016/0010-7824(74)90098-5 Goldberg, 1985, Suppression of plasma testosterone leads to an increase in serum total and high density lipoprotein cholesterol and apoproteins A-I and B, J Clin Endocrinol Metab, 60, 203, 10.1210/jcem-60-1-203 Goldzieher, 1984, Antifertility effects of progestational steroids, 49 Haffner, 1983, Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy, Metabolism, 32, 413, 10.1016/0026-0495(83)90052-5 Handelsman, 1990, Pharmacokenetics and pharmacodynamics of testerone pellets in man, J Clin Endocrinol Metab, 70, 216, 10.1210/jcem-71-1-216 Handelsman, 1992, Suppression of human spermatogenesis by testosterone implants, J Clin Endocrinol Metab, 75, 1326 Harris, 1977, Effects of testosterone and dihydrotestosterone on spermatogenesis, rete testis fluid, and peripheral androgen levels in hypophysecto mized rats, Fertil Steril, 28, 1113, 10.1016/S0015-0282(16)42865-7 Heber, 1984, The stimulatory and down-regulatory effects of a gonadotropin-releasing hormone agonist in man, J Clin Endocrinol Metab, 58, 1084, 10.1210/jcem-58-6-1084 Heber, 1982, Pituitary desensitization and the regulation of pituitary gonadotropin-releasing hormone (GnRH) receptors following chronic administration of a superactive GnRH analog and testosterone, Life Sci, 30, 2301, 10.1016/0024-3205(82)90257-0 Heber, 1982, Pituitary receptor site blockade by a gonadotropin-releasing hormone antagonist in vivo: Mechanism of action, Science, 216, 420, 10.1126/science.6280278 Heber, 1980, Male contraception: Synergism of gonadotropin-releasing hormone analog and testosterone in suppressing gonadotropin, Science, 209, 936, 10.1126/science.6773142 Heber, 1981, Gonadotropin-releasing hormone analog and testosterone synergistically inhibit spermatogenesis, Endocrinology, 108, 2019, 10.1210/endo-108-5-2019 Hedman, 1988, Endocrine, seminal and peripheral effects of depot medroxyprogesterone acetate and testosterone enanthate in men, Int J Androl, 11, 265, 10.1111/j.1365-2605.1988.tb01000.x Heller, 1959, Effects of progesterone and synthetic progestins on the reproductive physiology of normal men, Fed Proc, 18, 1057 Holmang, 1993, Effect of long-term oral testosterone undecanoate treatment on prostate volume and serum prostate-specific antigen concentration in eugonadal middle-aged men, Prostate, 23, 99, 10.1002/pros.2990230203 Hook, 1985, Histamine release by structural analogs of LHRH, Fed Proc, 44, 1323 Hsueh, 1981, Extrapituitary actions of gonadotropin-releasing hormone, Endocr Rev, 2, 437, 10.1210/edrv-2-4-437 Hsueh, 1979, Extra-pituitary inhibition of testicular function by luteinising hormone releasing hormone, Nature, 281, 66, 10.1038/281066a0 Huang, 1987, Restoration of spermatogenesis by high levels of testosterone by hypophysectomized rats after long-term regression, Acta Endocrinol, 116, 433, 10.1530/acta.0.1160433 Hug, 1990, Bangladesh Fertility Survey 1989. Main report, Dhaka National Institute of Population Research and Training. Huhtaniemi, 1985, Treatment of prostate cancer with a gonadotropin-releasing hormone agonist analog: Acute and long term effects on endocrine functions of testis tissue, J Clin Endocrinol Metab, 61, 698, 10.1210/jcem-61-4-698 Ilori, 1981, Sex differentials in attitude to family size in Nigeria and their implications for family planning programmes, 209 Jackson, 1989, Prostate complications of testosterone replacement therapy, Arch Intern Med, 149, 2365, 10.1001/archinte.1989.00390100157033 Kantor, 1985, Androgens reduce HDL2-cholesterol and increase hepatic triglyceride lipase activity, Med Sci Sports Exerc, 17, 462, 10.1249/00005768-198508000-00010 Karten, 1986, Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: Rationale and perspective, Endocr Rev, 7, 44, 10.1210/edrv-7-1-44 Keane, 1988, Response of the benign hypertrophied prostate to treatment with an LHRH analogue, Br J Urol, 62, 163, 10.1111/j.1464-410X.1988.tb04299.x Keith, 1975, Attitudes of men toward contraception, Arch Gynaecol, 22, 89, 10.1007/BF00667114 King, 1990, Health is a sustainable state, Lancet, 336, 664, 10.1016/0140-6736(90)92156-C Kirkland, 1987, Decrease in plasma high-density lipoprotein cholesterol levels at puberty in boys with delayed adolescence, JAMA, 257, 502, 10.1001/jama.1987.03390040118029 Kjeld, 1979, Effects of norgestrel and ethinyloestradiol ingestion on serum levels of sex hormones and gonadotropins in men, Clin Endocrinol, 11, 497, 10.1111/j.1365-2265.1979.tb03102.x Knuth, 1985, Clinical trial of 19-nortestosterone-hexoxyphenyl-propionate (Anadur) for male fertility regulation, Fertil Steril, 44, 814, 10.1016/S0015-0282(16)49043-6 Knuth, 1989, Combination of 19-nortestosterone-hexyloxyphe-nylpropionate (Anadur) and depot medroxyprogesterone-acetate (Clinovir) for male contraception, Fertil Steril, 51, 1011, 10.1016/S0015-0282(16)60735-5 Koch, 1976, Continuous oral low-dosage cyproterone acetate for fertility regulation in the male? A trend analysis in 15 volunteers, Contraception, 14, 117, 10.1016/0010-7824(76)90081-0 Konig, 1991, Revolution bei der Verhutung: Jetzt sind die manner dran, Stern 24/, 91, 28 Koya, 1959, Five-year experiment on family planning among coal miners in Japan, Popul Studies, 13, 157, 10.1080/00324728.1959.10405038 Kwekkeboom, 1990, Prolonged treatment with the GnRH analogue buserelin does not affect a-subunit production by the pituitary gondadotroph, Clin Endocrinol, 32, 443, 10.1111/j.1365-2265.1990.tb00884.x Labrie, 1978, Inhibitory effect of LHRH and its agonists on testicular gonadotrophin receptors and spermatogenesis in the rat, Int J Androl, 2, 303, 10.1111/j.1365-2605.1978.tb00024.x Labrie, 1980, Antifertility effects of LHRH agonists in the male, J Androl, 1, 209, 10.1002/j.1939-4640.1980.tb00034.x Lee, 1979, Clinical trial of reversible male contraceptive with long-acting sex hormones, Seoul J Med, 20, 1 Leonard, 1977, Contraceptive development studies for males: Oral and parenteral steroid hormone administration, 223 Lesser, 1955, Effect of testosterone propianate on the prostate gland of patients over 45, J Clin Endocrinol Metab, 15, 297, 10.1210/jcem-15-3-297 Linde, 1981, Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men, N Engl J Med, 305, 663, 10.1056/NEJM198109173051203 Lukkarinen, 1991, Effect of LH-RH analogue in patients with benign prostatic hyperplasia, Urology, 37, 92, 10.1016/0090-4295(91)80199-H Mann, 1987, Effect of continuous infusion of a low dose of GnRH antagonist on serum LH and testosterone concentrations, spermatogenesis and semen quality in the rhesus monkey (Macaca mulatto), J Reprod Fertil, 81, 485, 10.1530/jrf.0.0810485 Mann, 1984, Influence of continuous gonadotropin-releasing hormone (GnRH) agonist treatment of luteinizing hormone and testosterone secretion, the response to GnRH, and the testicular response to human chorionic gonadotropin in male rhesus monkeys, J Clin Endocrinol Metab, 58, 262, 10.1210/jcem-58-2-262 Mann, 1987, Influence of simultaneous gonadotropin-releasing hormone agonist and testosterone treatment on spermatogenesis and potential fertilizing capacity in male monkeys, J Clin Endocrinol Metab, 65, 1215, 10.1210/jcem-65-6-1215 Marshall, 1986, Maintenance of complete but quantitatively reduced spermatogenesis in hypophysectomized monkeys by testosterone alone, Acta Endocrinol, 113, 424, 10.1530/acta.0.1130424 Marshall, 1984, Testosterone can initiate spermatogenesis in an immature nonhuman primate, Macaca fascicularis, Endocrinology, 114, 2228, 10.1210/endo-114-6-2228 Matikainen, 1992, Differing responses of plasma bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone to gonadotropin-releasing hormone antagonist and agonist treatments in postmenopausal women, J Clin Endocrinol Metab, 75, 820 Matsumoto, 1988, Is high dosage testosterone an effective male contraceptive agent?, Fertil Steril, 50, 324, 10.1016/S0015-0282(16)60081-X Matsumoto, 1990, Effects of chronic testosterone administration in normal men: Safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of LH, FSH, and sperm production, J Clin Endocrinol Metab, 70, 282, 10.1210/jcem-70-1-282 Matsumoto, 1984, Modulation of pulsatile gonadotropin secretion by testosterone in man, J Clin Endocrinol Metab, 58, 609, 10.1210/jcem-58-4-609 Matsumoto, 1989, Endocrine control of human spermatogenesis, J Steroid Biochem, 33, 789, 10.1016/0022-4731(89)90493-7 Matsuo, 1971, Structure of the porcine LH-and FSH-releasing hormone, Biochem Biophys Res Commun, 43, 1334, 10.1016/S0006-291X(71)80019-0 Matzkin, 1991, Treatment of benign prostatic hypertrophy by a long-acting gonadotropin releasing hormone analogue: 1-year experience, J Urol, 145, 309, 10.1016/S0022-5347(17)38324-6 Mauldin, 1988, Prevalence of contraceptive use: Trends and issues, Stud Fam Plan, 19, 335, 10.2307/1966628 McNamara, 1982, Demographic transition theory, 146 Meikle, 1992, Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men, J Clin Endocrinol Metab, 74, 623 Melo, 1977, Inhibition of spermatogenesis in men with monthly injections of medroxyprogesterone acetate and testosterone enanthate, Contraception, 15, 627, 10.1016/S0010-7824(77)80001-2 1986, Men: new focus for family planning programs, Popul Rep, 14, J889 Mess, 1952, Influence of hypothalamic injury on spermatogenesis in albino rats, Acta Morphol, 2, 275 Michel, 1985, Failure of high-dose sustained release luteinizng hormone releasing hormone agonist (buserelin) plus oral testosterone to suppress male fertility, Clin Endocrinol, 23, 663, 10.1111/j.1365-2265.1985.tb01127.x Moltz, 1980, Medium-dose cyproterone acetate (CPA): Effects on hormone secretion and on spermatogenesis in men, Contraception, 21, 393, 10.1016/S0010-7824(80)80017-5 Morris, 1981 Morse, 1973, Testosterone concentrations in testes of normal men: Effects of testosterone propionate administration, J Clin Endocrinol Metab, 37, 882, 10.1210/jcem-37-6-882 Murty, 1979, Effect of passive immunization with specific antiserum to FSH on the spermatogenic process and fertility of male bonnet monkeys (Macaca radiata), J Reprod Fertil, 26, 147 Mustafa, 1984, Male attitudes towards family planning in Khartoum, Sudan, J Biosocial Sci, 16, 437, 10.1017/S0021932000015273 Nelson, 1952, Inter-relations of gonadotropic and gonadal hormones in the regulation of testicular functions, Ciba Found Colloq Endocrinol, 4, 271 Nieschlag, 1985, Reasons for abandoning immunization against FSH as an approach to fertility regulation, 395 Nieschlag, 1992, Hormonal male contraception: A real chance?, 477 Nieschlag, 1978, Clinical trial with testosterone undecanoate for male fertility control, Contraception, 18, 607, 10.1016/0010-7824(78)90045-8 Olukoya, 1985, The changing attitude and practice of men regarding family planning in Lagos, Nigeria, Public Health (London), 99, 349, 10.1016/S0033-3506(85)80082-2 Pangkahila, 1991, Reversible azoospermia induced by an androgen-progestin combination regimen in Indonesian men, Int J Androl, 14, 248, 10.1111/j.1365-2605.1991.tb01089.x Paulsen, 1985, Androgen-progestogen combinations, 300 Paulsen, 1982, Male contraception: Clinical trials, 157 Pavlou, 1989, Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men, J Clin Endocrinol Metab, 68, 446, 10.1210/jcem-68-2-446 Pavlou, 1991, Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido, J Clin Endocrinol Metab, 73, 1360, 10.1210/jcem-73-6-1360 Pavlou, 1988, Maintenance of the ratio of bioactive to immunoreactive follicle-stimulating hormone in normal men during chronic luteinizing hormone releasing hormone agonist administration, J Clin Endocrinol Metab, 66, 1005, 10.1210/jcem-66-5-1005 Pavlou, 1986, Single subcutaneous doses of a luteinizing hormone-releasing hormone antagonist suppress serum gonadotropin and testosterone levels in normal men, J Clin Endocrinol Metab, 63, 303, 10.1210/jcem-63-2-303 Pavlou, 1986, Heterogeneity of sperm density profiles following 16-week therapy with continuous infusion of high-dose LHRH analog plus testosterone, J Androl, 7, 228, 10.1002/j.1939-4640.1986.tb00920.x Pavlou, 1990, Persistence of concordant luteinizing hormone, testosterone, and a-subunit pulses after LH-releasing hormone antagonist administration in normal men, J Clin Endocrinol Metab, 70, 1472, 10.1210/jcem-70-5-1472 Pelletier, 1978, Inhibition of spermatogenesis in the rat by treatment with (D-Ala)6, des-Gly-NH210) LHRH ethylamide, Endocrinology, 103, 641, 10.1210/endo-103-2-641 Perrin, 1980, High affinity GnRH binding to testicular membrane homogenates, Life Sci, 26, 2251, 10.1016/0024-3205(80)90210-6 Peters, 1987, The effect of nafarelin acetate, a luteinizing-hormone-releasing-hormone agonist, on benign prostatic hyperplasia, N Engl J Med, 317, 599, 10.1056/NEJM198709033171004 Pinski, 1992, Comparison of biological effects of a sustained delivery system and nonencapsulated LH-RH antagonist SB-75 in rats, Peptides, 13, 905, 10.1016/0196-9781(92)90048-8 Pollard, 1982, Induction of prostate adenocarcinomas in Lobund Wistar rats by testosterone, Prostate, 3, 563, 10.1002/pros.2990030605 1986, 175 1991, 5 Potts, 1985, Male contraception in family planning programs, 2 Prasad, 1970, Fertility control in male rat by continuous release of microquantities of cyproterone acetate from subcutaneous silastic capsules, Contraception, 2, 165, 10.1016/S0010-7824(70)80023-3 Presser, 1975, Male versus female sterilization: Couple selectivity and the role of the physician Quian, 1987, Tripterygium wilfordii, a new lead in male fertility regulation, 217 Rabin, 1984, Heterogeneity of sperm density profiles following 20-week therapy with high-dose LHRH analog plus testosterone, J Androl, 5, 176, 10.1002/j.1939-4640.1984.tb02390.x Raj, 1982, Control of spermatogenesis in primates: Effects of active immunization against FSH in monkey, Int J Androl, 5, 27, 10.1111/j.1365-2605.1982.tb00301.x Rajalakshmi, 1989, Pharmacokinetics and pharmacodynamics of a new long-acting androgen ester: Maintenance of physiological androgen levels for 4 months after a single injection, Contraception, 40, 399, 10.1016/0010-7824(89)90048-6 Rajfer, 1987, Lack of a direct effect of gonadotropin hormone-releasing hormone agonist on human testicular steroidogenesis, J Clin Endocrinol Metab, 64, 62, 10.1210/jcem-64-1-62 Rajfer, 1984, Testicular histology following chronic gonadotropin-releasing hormone agonist treatment, Fertil Steril, 42, 765, 10.1016/S0015-0282(16)48205-1 Rao, 1987, Contraceptive needs in the 21st century: A demographic analysis, 1 Rea, 1986, Testosterone maintains pituitary and serum FSH and spermatogenesis in gonadotropin-releasing hormone antagonist-suppressed rats, J Endocrinol, 108, 101, 10.1677/joe.0.1080101 Rea, 1986, Testosterone stimulates pituitary and serum FSH in GnRH antagonist-suppressed rats, Acta Endocrinol, 113, 487, 10.1530/acta.0.1130487 Resko, 1982, Effects of chronic treatment with a potent luteinizing hormone releasing hormone agonist on serum luteinizing hormone and steroid levels in the male rhesus monkey, Biol Reprod, 26, 378, 10.1095/biolreprod26.3.378 Riphagen, 1985 Rivier, 1980, Anti-reproductive effects of a potent gonadotropin-releasing hormone antagonist in the male rat, Science, 210, 93, 10.1126/science.6774418 Rivier, 1981, Effect of a potent antagonist and testosterone propionate on mating behavior and fertility in the male rat, Endocrinology, 108, 1998, 10.1210/endo-108-5-1998 Rowley, 1977, Summary of studies utilizing androgens in the normal human male, 145 Roy, 1976, Effects of cyproterone acetate on reproductive functions in normal human males, Contaception, 14, 403, 10.1016/S0010-7824(76)80055-8 Salameh, 1991, Marked suppression of gonadotropins and testosterone by an antagonist analog of gonadotropin-releasing hormone in men, Fertil Steril, 55, 156, 10.1016/S0015-0282(16)54076-X Salehian, 1994, Comparison of pharmacokinetics of testosterone after sublingual testosterone or testosterone enanthate injections, Clin Res, 42, 74 Santen, 1984, Long term effects of administration of a gonadotropin-releasing hormone superagonist analog in men with prostatic carcinoma, J Clin Endocrinol Metab, 58, 397, 10.1210/jcem-58-2-397 Schaison, 1984, Absence of a direct inhibitory effect of the gonadotropin-releasing hormone (GnRH) agonist D-Ser (TBU)6, des-Gly-NH210 GnRH ethylamide (buserelin) on testicular steroidogenesis in men, J Clin Endocrinol Metab, 58, 885, 10.1210/jcem-58-5-885 Schally, 1987, Male contraception involving testosterone supplementation: Possible increased risks of prostate cancer, Lancet, 1, 448, 10.1016/S0140-6736(87)90149-8 Schearer, 1978, Hormonal contraception for men, Int J Androl, 2, 680, 10.1111/j.1365-2605.1978.tb00517.x Schmidt, 1984, A potent antagonist of LHRH, produces transient edema and behavioral changes in rats, Contraception, 29, 283, 10.1016/S0010-7824(84)80008-6 Schurmeyer, 1984, Reversible azoospermia induced by the anabolic steroid 19-nortestosterone, Lancet, i, 417, 10.1016/S0140-6736(84)91752-5 Schurmeyer, 1984, Suppression of pituitary and testicular function in normal men by constant gonadotropin-releasing hormone agonist infusion, J Clin Endocrinol Metab, 59, 19, 10.1210/jcem-59-1-19 Segal, 1985, 1 Sharpe, 1994, Regulation of spermatogenesis, 1363 Sheckter, 1989, Testosterone administration inhibits gonadotropin secretion by an effect directly on the human pituitary, J Clin Endocrinol Metab, 68, 397, 10.1210/jcem-68-2-397 Sherins, 1983, Hypogonadotrophic hypogonadism in men, 354 Skoglund, 1973, Danazol-testosterone combination: A potentially effective means for reversible male contraception. A preliminary report, Contraception, 7, 357, 10.1016/0010-7824(73)90138-8 Sorva, 1988, Effects of endogenous sex steroids on serum lipoproteins and postheparin plasma lipolytic enzymes, J Clin Endocrinol Metab, 66, 408, 10.1210/jcem-66-2-408 Sorva, 1988, Testosterone substitution increases the activity of lipoprotein lipase and hepatic lipase in hypogonadal males, Atherosclerosis, 69, 191, 10.1016/0021-9150(88)90014-7 Soufir, 1983, Reversible inhibition of sperm production and gonadotrophin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment, Acta Endocrinol, 102, 625, 10.1530/acta.0.1020625 Srinath, 1983, Active immunization with follicle-stimulating hormone for fertility control: A 4 1/2-year study in male rhesus monkeys, Fertil Steril, 40, 110, 10.1016/S0015-0282(16)47187-6 St. Arnaud, 1984, Pituitary desensitization and loss of luteinizing hormone bioactivity in men with cancer of the prostate following chronic treatment with an LHRH agonist and an antiandrogen, J Steroid Biochem, 20, 1408, 10.1016/0022-4731(84)90500-4 St. Arnaud, 1986, Serum luteinizing hormone (LH) biologic activity in castrated patients with cancer of the prostate receiving a pure antiandrogen and in estrogen-pretreated patients treated with an LH-releasing hormone agonist and antiandrogen, J Clin Endocrinol Metab, 63, 297, 10.1210/jcem-63-2-297 Steinberger, 1977, Effect of chronic administration of testosterone enanthate on sperm production and plasma testosterone, FSH, and LH levels: A preliminary evaluation of a possible male contraceptive, Fertil Steril, 28, 1320, 10.1016/S0015-0282(16)42977-8 Steinberger, 1977, Testosterone enanthate: A possible reversible male contraceptive, Contraception, 16, 261, 10.1016/0010-7824(77)90025-7 Swerdloff, 1979, Suppression of human spermatogenesis by depot androgen: Potential for male contraception, J Steroid Biochem, 11, 663, 10.1016/0022-4731(79)90097-9 Swerdloff, 1989, Male contraception: 1988 and beyond, 547 Swerdloff, 1988, Evaluation of the infertile couple, Endocrinol Metab Clin North Am, 17, 301, 10.1016/S0889-8529(18)30423-7 Taggart, 1982, Reduction in high density lipoproteins by anabolic steroid (Stanozolol) therapy for postmenopausal osteoporosis, Metabolism, 31, 1147, 10.1016/0026-0495(82)90166-4 Thompson, 1989, Contrasting effects of testosterone and stanozolol on serum lipoprotein levels, JAMA, 261, 1165, 10.1001/jama.1989.03420080085036 Tolis, 1981, Suppression of androgen production by D-tryptophan-6-luteinizing hormone-releasing hormone in man, J Clin Invest, 68, 819, 10.1172/JCI110320 Tom, 1992, Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate, J Clin Endocrinol Metab, 75, 476 Turner, 1982, Androgens, behaviour and fertility control in feral stallions, J Reprod Fertil, 32, 79 Van der Merwe, 1982 Verhoeven, 1992, Local control systems within the testis, Bailliere’s Clin Endocrinol Metab, 6, 313, 10.1016/S0950-351X(05)80152-1 Vickery, 1986, Comparison of the potential for therapeutic utilities with gonadotropin-releasing hormone agaonists and antagonists, Endocr Rev, 7, 115, 10.1210/edrv-7-1-115 Wallace, 1992, Residual sperm function in oligozoospermia induced by testosterone enanthate administered as a potential steroid male contraceptive, Int J Androl, 15, 416, 10.1111/j.1365-2605.1992.tb01356.x Wallace, 1993, Prostate-specific antigen and prostate gland size in men receiving exogenous testosterone for male contraception, Int J Androl, 16, 35, 10.1111/j.1365-2605.1993.tb01150.x Wallace, 1990, Effect of depot medroxyprogesterone acetate and testosterone oenanthate on serum lipoproteins in man, Contraception, 41, 63, 10.1016/0010-7824(90)90127-H Wang, 1980, Use of low-dosage oral cyproterone acetate as a male contraceptive, Contraception, 21, 245, 10.1016/0010-7824(80)90005-0 Webb, 1984, Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic-androgenic steroids, Metabolism, 33, 971, 10.1016/0026-0495(84)90222-1 Weinbauer GF, Behre HM, Nieschlag E, et al: Concomitant but not delayed androgen supplementation prevents complete testicular involution in GnRH antagonist-treated non-human primates [abstract 1075]. In Programs & Abstracts of the Endocrine Society 74th Annual Meeting, San Antonio, 1992, p 320 Weinbauer, 1988, Testosterone prevents complete suppression of spermatogenesis in the gonadotropin-releasing hormone antagonist-treated nonhuman primate (Macaca fascicularis), J Clin Endocrinol Metab, 67, 284, 10.1210/jcem-67-2-284 Weinbauer, 1992, Exogenous gonadotropin-releasing hormone (GnRH) stimulates LH secretion in male monkeys (Macaca fascicularis) treated chronically with high doses of a GnRH antagonist, J Endocrinol, 133, 439, 10.1677/joe.0.1330439 Weinbauer, 1989, Sustained inhibition of sperm production and inhibin secretion induced by a gonadotrophin-releasing hormone antagonist and delayed testosterone substitution in non-human primates (Macaca fascicularis), J Endocrinol, 123, 303, 10.1677/joe.0.1230303 Weinbauer, 1986, New injectable testosterone ester maintains serum testosterone of castrated monkeys in the normal range for four months, Acta Endocrinol, 113, 128, 10.1530/acta.0.1130128 Weinbauer, 1984, Reversible inhibition of testicular function by a gonadotropin hormone-releasing hormone antagonist in monkeys (Macaca fascicularis), Fertil Steril, 42, 906, 10.1016/S0015-0282(16)48264-6 Weinbauer, 1987, Suppression of spermatogenesis in a nonhuman primate (Macaca fascicularis) by concomitant gonadotropin-releasing hormone antagonist and testosterone treatment, Acta Endocrinol, 114, 138, 10.1530/acta.0.1140138 1990, Contraceptive efficacy of testosterone-induced azoospermia in normal men, Lancet, 336, 955, 10.1016/0140-6736(90)92416-F 1993, Comparison of two androgens plus depot-medroxyprogesterone acetate for suppression to azoospermia in Indonesian men, Fertil Steril, 60, 1062, 10.1016/S0015-0282(16)56411-5 WHO Special Programme of Research Development and Research Training in Human Reproduction: Seventh Annual Report. Geneva, 1978, p 92 Wickings, 1980, The role of follicle stimulating hormone in testicular function of the mature rhesus monkey, Acta Endocrinol, 95, 117, 10.1530/acta.0.0950117 Woods, 1985 Wrigley, 1969, 188 Wu, 1989, Suppression of sperm function by depot medroxyprogesterone acetate and testosterone enanthate in steroid male contraception, Fertil Steril, 51, 691, 10.1016/S0015-0282(16)60623-4 Young, 1993, Body composition and muscle strength in healthy men receiving testosterone enanthate for contraception, J Clin Endocrinol Metab, 77, 1028 Zmuda, 1993, The effect of testosterone aromatization on high-density lipoprotein cholesterol level and postheparin lipolytic activity, Metabolism, 42, 446, 10.1016/0026-0495(93)90101-S